Baxter International Inc. (BAX) Covered Calls
Baxter International Inc. is a global medical technology leader that develops and manufactures a broad portfolio of essential healthcare products. The company provides critical solutions for medication delivery, advanced surgery, clinical nutrition, and pharmaceutical automation. Through its innovative medical devices and diagnostic tools, Baxter supports healthcare professionals in hospitals, clinics, and home settings to improve patient outcomes across the continuum of care.
You can sell covered calls on Baxter International Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BAX (prices last updated Wed 4:16 PM ET):
| Baxter International Inc. (BAX) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 18.31 | -0.18 | 18.00 | 18.65 | 4.6M | - | 10 |
| Covered Calls For Baxter International Inc. (BAX) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| May 15 | 18.5 | 0.95 | 17.70 | 4.5% | 68.4% | |
| Jun 18 | 17.5 | 1.85 | 16.80 | 4.2% | 26.4% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Core Business and Products
Baxter International Inc. (BAX) is a diversified healthcare company that produces a wide array of products used in hospitals and clinics worldwide. The company’s core portfolio is centered on medication delivery systems, including IV solutions, infusion pumps, and administration sets. It is a leading provider of clinical nutrition products, offering parenteral nutrition therapies for patients who cannot receive adequate nutrients through traditional means. Additionally, Baxter’s advanced surgery segment provides specialized biological sealants and hemostats used to manage bleeding during complex surgical procedures.
The company also operates a significant pharmaceuticals business that focuses on premixed injectable drugs, inhaled anesthetics, and pharmacy compounding services. By integrating hardware, software, and medicinal products, Baxter seeks to enhance patient safety and clinical efficiency. Following the strategic divestiture of its kidney care business, the company has refocused its resources on higher-growth segments like "Connected Care" technologies, which utilize data and AI-driven insights to streamline nursing workflows and monitor patient vitals in real-time.
Competitive Landscape
The medical device and pharmaceutical industries are highly competitive, requiring continuous investment in research and development to maintain market leadership. Baxter competes with other large-scale medical technology firms that offer similar lines of infusion systems, surgical tools, and injectable medications. Competition is based on product reliability, technological integration with hospital information systems, and the ability to provide a secure and efficient global supply chain.
- Becton, Dickinson and Company: A primary competitor in the medication delivery and infusion technology space.
- Medtronic: A major medical technology peer that competes across various surgical and critical care segments.
- ICU Medical: Competes directly with Baxter in the IV solutions and infusion therapy markets.
- Edwards Lifesciences: A key competitor in the advanced monitoring and critical care space.
- Fresenius Medical Care: A global peer in the broader healthcare services and medical products landscape, particularly in clinical settings.
Strategic Outlook and Innovation
The strategic focus of the company is centered on operational efficiency and the modernization of its manufacturing footprint. Management is prioritizing the expansion of its digital health capabilities, aiming to create a seamless ecosystem of connected devices that reduce the risk of medication errors and alleviate staff workloads. By focusing on "intelligent" infusion pumps and automated compounding systems, the company seeks to capture high-margin revenue streams in the evolving hospital environment.
Innovation efforts are also directed toward the development of sustainable manufacturing processes and the reduction of exposure to volatile raw material costs. The company is actively investing in next-generation surgical technologies and expanding its presence in emerging markets to drive long-term growth. Through a disciplined approach to portfolio optimization and a commitment to clinical excellence, the company aims to remain a vital partner to healthcare providers and a leader in the global medical technology sector.
| Top 10 Open Interest For May 15 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | TLT covered calls | 1. | NOW covered calls | |
| 2. | NVDA covered calls | 7. | HYG covered calls | 2. | QS covered calls | |
| 3. | IBIT covered calls | 8. | QQQ covered calls | 3. | POET covered calls | |
| 4. | GLD covered calls | 9. | KWEB covered calls | 4. | NOK covered calls | |
| 5. | SPY covered calls | 10. | EEM covered calls | 5. | TLRY covered calls | |
Want more examples? BATT Covered Calls | BB Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
